Related Experiment Video
Updated: Jun 12, 2026

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
Fas (CD95) induces rapid, TLR4/IRAK4-dependent release of pro-inflammatory HMGB1 from macrophages
Feng Wang1, Ziyue Lu, Michael Hawkes
1Department of Medicine, Toronto General Research Institute, McLaughlin-Rotman Centre for Global Health, McLaughlin Centre for Molecular Medicine, University Health Network, University of Toronto, Toronto, Ontario, Canada. conrad.liles@uhn.on.ca.
Abstract:
Although Fas (CD95) is recognized as a death receptor that induces apoptosis, recent studies indicate that the Fas/FasL system can induce pro-inflammatory cytokine production by macrophages independent of conventional caspase-mediated apoptotic signaling. The precise mechanism(s) by which Fas activates macrophage inflammation is unknown. We hypothesized that Fas stimulates rapid release of high mobility group box 1 (HMGB1) that acts in an autocrine and/or paracrine manner to stimulate pro-inflammatory cytokine production via a Toll-like receptor-4 (TLR4)/Interleukin-1 receptor associated kinase-4 (IRAK4)-dependent mechanism. Following Fas activation, HMGB1 was released within 1 hr from viable RAW267.4 cells and primary murine peritoneal macrophages. HMGB1 release was more rapid following Fas activation compared to LPS stimulation. Neutralization of HMGB1 with an inhibitory anti-HMGB1 monoclonal antibody strongly inhibited Fas-induced production of tumor necrosis factor (TNF) and macrophage inflammatory protein-2 (MIP-2). Both Fas-induced HMGB1 release and associated pro-inflammatory cytokine production were significantly decreased from Tlr4-/- and Irak4-/- macrophages, but not Tlr2-/- macrophages. These findings reveal a novel mechanism underlying Fas-mediated pro-inflammatory physiological responses in macrophages. We conclude that Fas activation induces rapid, TLR4/IRAK4-dependent release of HMGB1 that contributes to Fas-mediated pro-inflammatory cytokine production by viable macrophages.
Insights
Fas receptor activation triggers rapid release of high mobility group box 1 (HMGB1) from macrophages. This HMGB1 then stimulates pro-inflammatory cytokine production via Toll-like receptor 4 (TLR4) and IRAK4 signaling.
Area of Science:
- Immunology
- Cell Biology
- Molecular Signaling
Background:
- Fas receptor (CD95) traditionally induces apoptosis.
- Emerging evidence suggests Fas/FasL system promotes inflammation independently of apoptosis.
- The exact mechanism of Fas-induced macrophage inflammation remains unclear.
Purpose of the Study:
- To investigate the role of high mobility group box 1 (HMGB1) in Fas-mediated macrophage inflammation.
- To elucidate the signaling pathway involved in Fas-induced pro-inflammatory cytokine production.
Main Methods:
- Fas activation in RAW267.4 cells and primary murine macrophages.
- Measurement of HMGB1 release and pro-inflammatory cytokine (TNF, MIP-2) production.
- Utilized anti-HMGB1 antibodies and knockout macrophages (Tlr4-/-, Irak4-/-, Tlr2-/-).
Main Results:
- Fas activation rapidly released HMGB1 from viable macrophages within 1 hour.
- Neutralization of HMGB1 significantly reduced Fas-induced TNF and MIP-2 production.
- Fas-induced HMGB1 release and cytokine production were dependent on Toll-like receptor 4 (TLR4) and IRAK4, but not TLR2.
Conclusions:
- Fas receptor activation induces rapid, TLR4/IRAK4-dependent release of HMGB1.
- Released HMGB1 contributes to pro-inflammatory cytokine production by viable macrophages.
- Identifies a novel mechanism for Fas-mediated inflammatory responses in macrophages.
More Related Videos
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Acute Inflammation I: Inflammatory Response
Chronic Inflammation: Introduction
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Inflammatory Bowel Disease III: Crohn's Disease

